BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16788767)

  • 1. (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.
    Martínez-Gras I; Hoenicka J; Ponce G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Pérez-Hernandez E; Ampuero I; Ramos-Atance JA; Palomo T; Rubio G
    Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):437-41. PubMed ID: 16788767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
    Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia.
    Tsai SJ; Wang YC; Hong CJ
    Psychiatr Genet; 2000 Sep; 10(3):149-51. PubMed ID: 11204352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia.
    Chavarría-Siles I; Contreras-Rojas J; Hare E; Walss-Bass C; Quezada P; Dassori A; Contreras S; Medina R; Ramírez M; Salazar R; Raventos H; Escamilla MA
    Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):279-84. PubMed ID: 18186055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis.
    Benyamina A; Kebir O; Blecha L; Reynaud M; Krebs MO
    Addict Biol; 2011 Jan; 16(1):1-6. PubMed ID: 20192949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.
    Jiang Y; Nie Y; Li Y; Zhang L
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1186-91. PubMed ID: 24444427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders].
    Martínez-Gras I; Hoecnika J; Pérez-Hernández E; Rodríguez-Jiménez R; Ponce G; Jiménez-Arriero M; Ramos-Atance J; Palomo T; Rubio G
    Actas Esp Psiquiatr; 2007; 35(2):122-9. PubMed ID: 17401783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population.
    Ballon N; Leroy S; Roy C; Bourdel MC; Charles-Nicolas A; Krebs MO; Poirier MF
    Pharmacogenomics J; 2006; 6(2):126-30. PubMed ID: 16314880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor gene (CNR1): association with i.v. drug use.
    Comings DE; Muhleman D; Gade R; Johnson P; Verde R; Saucier G; MacMurray J
    Mol Psychiatry; 1997 Mar; 2(2):161-8. PubMed ID: 9106242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study.
    Park JM; Choi MG; Cho YK; Lee IS; Kim SW; Choi KY; Chung IS
    J Clin Gastroenterol; 2011 Jan; 45(1):45-9. PubMed ID: 20505532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes.
    Siegfried Z; Kanyas K; Latzer Y; Karni O; Bloch M; Lerer B; Berry EM
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):126-30. PubMed ID: 14755457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
    Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
    Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of CNR1 gene variations with susceptibility to schizophrenia.
    Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
    Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
    Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
    Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working memory performance in young adults is associated to the AATn polymorphism of the CNR1 gene.
    Ruiz-Contreras AE; Carrillo-Sánchez K; Gómez-López N; Vadillo-Ortega F; Hernández-Morales S; Carnevale-Cantoni A; Espejel-Núñez A; Méndez-Díaz M; Prospéro-García O
    Behav Brain Res; 2013 Jan; 236(1):62-66. PubMed ID: 22944513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia.
    Ujike H; Takaki M; Nakata K; Tanaka Y; Takeda T; Kodama M; Fujiwara Y; Sakai A; Kuroda S
    Mol Psychiatry; 2002; 7(5):515-8. PubMed ID: 12082570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of the
    Maciocha F; Suchanecka A; Chmielowiec K; Chmielowiec J; Ciechanowicz A; Boroń A
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3' region of the DRD2 gene.
    Hoenicka J; Ponce G; Jiménez-Arriero MA; Ampuero I; Rodríguez-Jiménez R; Rubio G; Aragüés M; Ramos JA; Palomo T
    Neurotox Res; 2007 Jan; 11(1):51-60. PubMed ID: 17449448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1.
    Leroy S; Griffon N; Bourdel MC; Olié JP; Poirier MF; Krebs MO
    Am J Med Genet; 2001 Dec; 105(8):749-52. PubMed ID: 11803524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.